CET on 9 December 2024 due to the following corrections: Updated subheadline. MaaT Pharma Presented Positive Updated Data on MaaT013 in the Early Access Program at ASH 2024 ...
Research shows that GBM organoids are a powerful, accurate tool for understanding what happens when treating a brain tumor ...
New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London provides valuable ...
Researchers from the United States and Germany have discovered a peptide that makes barley in the most important ...
Groundbreaking studies have recently shed light on the extent to which air pollution contributes to the development of ...
A group of scientists at VCU Massey Comprehensive Cancer Center has uncovered a new genetic code that deploys a cluster of ...
Poseida Therapeutics (PSTX) will highlight interim clinical data from its Phase 1 trial of P-BCMA-ALLO1 in patients with relapsed/refractory ...
For the first time, researchers have used lab-grown organoids created from tumors of individuals with glioblastoma (GBM) to ...
New research reveals that fetuses can mount immune responses against infections long before birth, challenging the assumption that they rely solely on maternal immunity.
Certain peptides can aid in weight loss through various mechanisms. For example, peptides like GLP-1 receptor antagonists can ...
Research from Duke-NUS Medical School has revealed that fetuses are not as defenseless as once thought; they can actually ...
The Amyloidosis market was $3.6 billion in 2017, and is expected to reach $6 billion in 2025, according to Grand View Research.